Evaluating Symptom Management Educational Materials for Patients With Prostate Cancer
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
RATIONALE: Collecting feedback from patients with prostate cancer may help doctors develop better symptom management educational materials for patients.
PURPOSE: This clinical trial is evaluating symptom management educational materials for patients with prostate cancer.
| Condition | Intervention |
|---|---|
|
Prostate Cancer |
Other: educational intervention Other: study of socioeconomic and demographic variables |
| Study Type: | Interventional |
| Official Title: | FOCUS GROUP EVALUATION OF PROSTATE CANCER SYMPTOM MANAGEMENT EDUCATION MATERIALS |
- Acceptability of the written patient educational materials, in terms of text size, white space, font, and graphics [ Designated as safety issue: No ]
- Formative evaluation of the new educational materials, in terms of the comments made by the focus group participants [ Designated as safety issue: No ]
- Validation that the goals of the educational-intervention instruction are being achieved [ Designated as safety issue: No ]
- Improvement of the educational-intervention instruction by identification and remediation of problems [ Designated as safety issue: No ]
| Estimated Enrollment: | 30 |
| Study Start Date: | May 2008 |
| Primary Completion Date: | April 2009 (Final data collection date for primary outcome measure) |
OBJECTIVES:
- To collect formative evaluation data about a new educational intervention using focus groups of patients with prostate cancer.
- To use the focus group data in the master's research paper of a Baylor College of Medicine physician-assistant student who is documenting the process of organizing and conducting the focus groups, enumerating areas where the new materials are deemed problematic, and identifying themes in the comments made by the focus group participants.
OUTLINE: Study participants are assigned to 1 of 3 focus groups according to educational level and ethnicity (i.e., lower educational-level African-American men primarily from the Michael E. DeBakey Veterans Affairs Medical Center (MEDVAMC); lower educational-level Caucasian men from MEDVAMC, Baylor College of Medicine (BCM), or the community; or higher educational-level Caucasian men primarily from BCM or the community).
Participants review written patient educational-intervention materials on prostate cancer and provide feedback to the investigator on the content and acceptability of these materials during a 1½-2-hour focus group discussion. Feedback data are used to revise the intervention materials so that they are appropriate to the target population.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | No |
DISEASE CHARACTERISTICS:
Biopsy-proven prostate cancer
- Localized disease that has been previously treated
Selected for participation from 1 of the following:
- Convenience sample of men from the Baylor College of Medicine (BCM) Urology clinics at Scurlock Tower (including the Urology clinic at MEDVAMC) and local prostate cancer-support groups
- Prostate cancer survivors who participated in the US TOO Father's Day Walk/Run or the Gay Pride Celebration
PATIENT CHARACTERISTICS:
- Able to speak and read in English
- Willing to review the written patient educational materials and discuss them in a group setting
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Contacts and Locations| United States, Texas | |
| Dan L. Duncan Cancer Center at Baylor College of Medicine | |
| Houston, Texas, United States, 77030 | |
| Veterans Affairs Medical Center - Houston | |
| Houston, Texas, United States, 77030 | |
| Principal Investigator: | David M. Latini, PhD | Baylor College of Medicine |
More Information
Additional Information:
No publications provided
| Responsible Party: | David M. Latini, Dan L. Duncan Cancer Center at Baylor College of Medicine |
| ClinicalTrials.gov Identifier: | NCT00769431 History of Changes |
| Other Study ID Numbers: | CDR0000600594, BCM-H-21622 |
| Study First Received: | October 8, 2008 |
| Last Updated: | February 18, 2011 |
| Health Authority: | United States: Federal Government |
Keywords provided by National Cancer Institute (NCI):
|
stage I prostate cancer stage IIB prostate cancer stage IIA prostate cancer |
Additional relevant MeSH terms:
|
Prostatic Neoplasms Genital Neoplasms, Male Urogenital Neoplasms Neoplasms by Site |
Neoplasms Genital Diseases, Male Prostatic Diseases |
ClinicalTrials.gov processed this record on June 18, 2013